Functional Nutrition for Cancer Survivors
…your diet and lifestyle to support a healthy and balanced immune system when living with melanoma. Dionne Detraz, RDN, is…
Functional Nutrition for Cancer Survivors
…your diet and lifestyle to support a healthy and balanced immune system when living with melanoma. Dionne Detraz, RDN, is…
,
While You’re Spring Cleaning, Create Your Will Online for Free
…by protecting the people and the causes close to your heart. While writing your will, you can make an optional…
,
Nailing Down on the Ultraviolet Exposure Occurring During the Curing and Drying of a Manicure
…used at home or in salons, the UV intensity penetrating the skin from nail lamps is comparable to tanning beds,…
Beyond the Clinic’s New Host: Introducing Dr. Sam Siegel
In this special episode of Beyond the Clinic: Living with Melanoma, Dr. Raymond Liu and Dr. Sam Siegel sit down…
,
Nivolumab at Micro Doses Works Better than Chemotherapy Against Relapsed Cancer
…life, and led to fewer side effects among cancers that were resistant to prior therapy. Although the study did not…
,
The Integrative Care Approach
Guest: Lisa Simms Booth, Executive Director, Smith Center for Healing and the Arts In this episode of the Beyond the…
,
The Cost of Sunscreen May Be Costing Lives
…its ability to protect skin is diminished, which increases the probability of sunburn and, in turn, the risk of melanoma.…
Cancer is More Than a Diagnosis: Mind, Meaning, and Healing
…Beyond the Clinic: Living Well with Melanoma, where Dr. Samantha Siegel and psycho-oncologist Dr. Xiomara Rocha Cadman explore the emotional…
,
Promising 5-year data for the individualized neoantigen therapy, intismeran autogene, in combination with pembrolizumab (Keytruda)
…(Keytruda), a checkpoint inhibitor that targets the immune system. In total, the trial enrolled 107 patients following melanoma surgery to…
,
Promising early results with imneskibart, low-dose subcutaneous IL-2, and nivolumab in patients who do not respond to or who relapse after receiving combination checkpoint inhibitors
…this Phase 1/2 study had metastatic melanoma whose disease progressed after receiving standard checkpoint inhibitor therapies such as ipilimumab (Yervoy)…
,
Recent Posts
Jun. 09, 2026
The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026